Annika Axelsson (Former)
1 – 5 of 12
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production
(
- Contribution to journal › Article
- 2017
-
Mark
Identification of new disease mechanisms and treatments for type 2 diabetes based on genetic variants and gene expression networks
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
Thrombin stimulates insulin secretion via protease-activated receptor-3.
(
- Contribution to journal › Article